跳至主要内容
临床试验/NCT03237273
NCT03237273Unknown不适用

HEAD-US SCORING SYSTEM: Assessment of the Real-world Impact of Ultrasound on Disease Management and Treatment Decision-making in Moderate and Severe Haemophilia

Guy's and St Thomas' NHS Foundation Trust0 个研究点目标入组 200 人开始时间: 2015年12月最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
200
主要终点
Any change in treatment

研究概览

简要总结

Ultrasound represents a promising technique for the assessment of joint health in persons with haemophilia (PWH) by non-imaging specialists. The Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US) programme has been developed with the aim of integrating joint ultrasound in the routine assessment of PWH through the use of a simplified scoring system. The inter-operator reliability of the technique among European haemophilia treaters has been validated and described elsewhere. Further work is needed to assess the real-world impact of ultrasound on disease management and treatment decision-making.

详细描述

Patients are seen routinely in clinic by specialist haemophilia physiotherapists who assess the patients using the Haemophilia Joint Health Score tool (HJHS). Trial participants will be seen during their routine clinic visits and will be seen by a clinician and the physiotherapist who will carry out the routine assessment along with the HEAD-US scan.

Patients will be seen a maximum of 4 times throughout the year from registration of the first patient, according to their visit schedule, but will only be scanned at the first visit.

Results will be analysed to determine if the treatment decision-making is influenced by the results of the scan

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
6 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Moderate (FVIII/FIX:C 1-5%) and severe (FVIII/FIX: C <1%) patients with haemophilia A or B aged ≥ 6 years
  • On demand or prophylaxis treatment regimen

排除标准

  • Joints with a previous history of surgery
  • Joints with damage as a result of causes other than haemophilia-related bleeding

研究组 & 干预措施

Single

Experimental

All patients will undergo ultrasound scan using the HEAD-US Scoring System by a non-imaging specialist

干预措施: HEAD-US scoring system (Other)

结局指标

主要结局

Any change in treatment

时间窗: 12 months

Any change in treatment including, management of a bleed and/or change in routine treatment protocol (including changes to prophylaxis regimen, or decision to start/stop prophylaxis regimen) as a result of the ultrasound findings

次要结局

  • % joints with normal HJHS and abnormal HEAD-US score(12 months)
  • % joints with abnormal HJHS and normal HEAD-US score(12 months)

研究者

申办方类型
Other
责任方
Sponsor

相似试验